VC Deals Analysis: 2018 Off To A Flying Start
Executive Summary
Venture financing activity hit the ground running in 2018 after a bumper haul of mega-raises brought the total deal value for January close to $1bn.
You may also be interested in...
VC Deals Analysis: Asia Investors Pour Money Into Grail And May's Other Big Deals
Asian investors' unrelenting pursuit of medtech ventures continued to crescendo in May. The participants in the largest round so far this year, the $300m series C by Illumina spin-out Grail, are all China-based funds.
Boston Scientific Hooks In Millipede, But Still Trailing Behind In Mitral Valve Race
Boston Scientific is pumping money into the high-potential mitral valve repair space by making a strategic investment in Millipede, as well as signing an acquisition option agreement that could be worth nearly half a billion dollars. However, its cardiovascular rivals are already some distance ahead in this space.
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.